<div dir="ltr">
<p><font size="4">"Gene therapy has shown promise in recent years for treating a range of diseases, including <a href="https://singularityhub.com/2019/12/17/gene-therapy-for-sickle-cell-anemia-looks-promising-but-its-riddled-with-controversy/">sickle-cell anemia</a>, <a href="https://www.sciencedirect.com/science/article/abs/pii/S1473050219301570">hemophilia</a>, various forms of <a href="https://singularityhub.com/2020/03/03/gene-therapy-is-successfully-treating-a-common-form-of-inherited-blindness">inherited blindness</a>, <a href="https://www.mesothelioma.com/treatment/gene-therapy/">mesothelioma</a>, and <a href="https://singularityhub.com/2020/07/30/a-year-after-getting-gene-therapy-boys-with-muscular-dystrophy-are-healthier-and-stronger/">Duchenne muscular dystrophy</a>.
 A new success story may soon be added to this list, with the 
publication yesterday of the outcomes of a clinical trial that used gene
 therapy to cure a rare immune system disorder in infants.</font></p><font size="4">
</font><p><font size="4">The study, described in the <em><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2027675">New England Journal of Medicine</a>,</em>
 was carried out by researchers from UCLA and Great Ormond Street 
Hospital in London over the course of five years, beginning in 2012."</font></p><p><font size="4"><a href="https://singularityhub.com/2021/05/13/how-one-round-of-gene-therapy-repaired-a-dysfunction-in-48-kids-immune-systems/">https://singularityhub.com/2021/05/13/how-one-round-of-gene-therapy-repaired-a-dysfunction-in-48-kids-immune-systems/</a></font></p>

</div>